ABSTRACT
OBJECTIVE: To review the management, success, and complication rates of women who presented with a cesarean scar ectopic pregnancy at an Australian tertiary referral center. METHODS: A retrospective case series was undertaken. Patients were identified through the hospital's clinical information services coding system and data were collected from medical records. RESULTS: A total of 38 cases were identified. Patients who were hemodynamically stable were predominantly managed according to local expertise via intramuscular, intra-sac methotrexate or a combination of these two. In some cases, surgical management was preferred. CONCLUSION: Cesarean scar ectopic pregnancy may be managed both surgically and medically. At institutions where surgical expertise is unavailable, medical management would be valuable with few adverse outcomes identified, provided women have closely monitored follow-up.
Subject(s)
Abortifacient Agents, Nonsteroidal , Pregnancy, Ectopic , Pregnancy , Humans , Female , Cicatrix/surgery , Retrospective Studies , Tertiary Care Centers , Cesarean Section/adverse effects , Australia/epidemiology , Pregnancy, Ectopic/etiology , Pregnancy, Ectopic/surgery , Methotrexate/therapeutic use , Abortifacient Agents, Nonsteroidal/therapeutic useABSTRACT
The COVID-19 pandemic has significantly disrupted training in obstetrics and gynaecology. Past pandemics have been shown to result in significant psychological morbidity. As specialty trainees continue frontline work, they will face unprecedented work environments and may face delays in progression due to postponed examinations, case log shortfalls and inadequate clinical rotations. This contributes to burnout, anxiety and depression. We share technology-based suggestions as well as institutional, departmental and self-care tips on how to maintain trainees' mental well-being during the fight against COVID-19.
Subject(s)
Burnout, Professional/psychology , COVID-19 , Gynecology/education , Health Personnel/psychology , Obstetrics/education , Attitude of Health Personnel , Humans , Mental Health , SARS-CoV-2 , Surveys and Questionnaires , VideoconferencingABSTRACT
INTRODUCTION: Placenta accreta spectrum (PAS) covers a spectrum of placental adherence abnormalities: placenta accreta, increta and percreta. PAS is associated with significant maternal morbidity and mortality. Studies have shown the importance of multidisciplinary teamwork in the management of PAS. AIM: This study was designed to describe the maternal and neonatal morbidity and mortality associated with PAS in our centre over a ten-year period. METHODS: A retrospective cohort study was conducted of pregnancies complicated by PAS between February 2006 and January 2016 at Flinders Medical Centre (FMC), South Australia. Electronic and medical records were examined to obtain patient demographics, antenatal and surgical, findings and postnatal outcomes. RESULTS: There were 67 PAS cases with an overall incidence of 2.3 per 1000 deliveries. Three cases were excluded due to incomplete information. Of the remaining 64 cases, 56 women were antenatally diagnosed. Sixty cases were confirmed to be invasive at delivery; 28 accreta (superficial) and 32 increta/percreta (deep) cases. The four cases with no invasion at delivery were suspected antenatally to have PAS. The median (Q1, Q3) number of caesarean sections in this cohort was 2 (1, 3). Deep invasion is significantly associated with increased bleeding, intensive care unit admission, surgical complications and an extended postpartum stay. CONCLUSION: The incidence of PAS at FMC is high as it is the state's tertiary referral centre. While PAS is associated with increased morbidity, thorough perioperative planning by a multidisciplinary team is crucial for excellent patient outcomes.
Subject(s)
Patient Care Team/organization & administration , Placenta Accreta/diagnosis , Placenta Accreta/epidemiology , Postoperative Complications/epidemiology , Postpartum Hemorrhage/epidemiology , Adult , Cesarean Section , Female , Humans , Hysterectomy , Incidence , Length of Stay , Placenta Accreta/therapy , Pregnancy , Retrospective Studies , South AustraliaABSTRACT
OBJECTIVE: To determine if maternal circulating red blood cell (RBC) folate concentration in early pregnancy is associated with late gestation pregnancy complications including small for gestational age (SGA) infants, preeclampsia and preterm birth (PTB) in a socioeconomically disadvantaged population. METHOD: This was a retrospective case control study, conducted at Lyell McEwin Health Service, South Australia, including 400 primiparous women. RBC folate and demographic data were collected at 10-12 weeks gestation. Pregnancy outcome data were obtained from patient case notes. RESULTS: Patients who were folate deficient were more likely to develop pregnancy complications, specifically SGA (OR 6.9, 95% CI 2-24.3) and PTB (OR 5.4 95% CI 1.4-21.2). Those who were folate insufficient were also at increased risk of SGA (OR 3.0, 95% CI 1.3-7.7). No association between folate and preeclampsia was found. Women who were supplementing with folic acid delivered infants who were 179 g heavier (5.5% increased birth weight, P = 0.003) and 4.5 days later, compared to those who did not supplement. Furthermore, low RBC folate was associated with cigarette smoking (P < 0.001). CONCLUSIONS: Maternal RBC folate concentration in early pregnancy is associated with SGA and PTB, but not with preeclampsia.
